Sumit Aggarwal

2022

In 2022, Sumit Aggarwal earned a total compensation of $1.4M as Chief Executive Officer at Sevion Therapeutics, a 75% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$253,022
Option Awards$556,270
Salary$575,050
Other$11,600
Total$1,395,942

Aggarwal received $575.1K in salary, accounting for 41% of the total pay in 2022.

Aggarwal also received $253K in non-equity incentive plan, $556.3K in option awards and $11.6K in other compensation.

Rankings

In 2022, Sumit Aggarwal's compensation ranked 2,380th out of 5,736 executives tracked by ExecPay. In other words, Aggarwal earned more than 58.5% of executives.

ClassificationRankingPercentile
All
2,380
out of 5,736
59th
Division
Manufacturing
1,308
out of 3,125
58th
Major group
Chemicals And Allied Products
583
out of 1,416
59th
Industry group
Drugs
538
out of 1,317
59th
Industry
Biological Products, Except Diagnostic Substances
131
out of 291
55th
Source: SEC filing on April 28, 2023.

Aggarwal's colleagues

We found two more compensation records of executives who worked with Sumit Aggarwal at Sevion Therapeutics in 2022.

2022

Vijay Modur

Sevion Therapeutics

Head of Research and Development

2022

Daniel Geffken

Sevion Therapeutics

Chief Financial Officer

News

You may also like